Mast cells: new therapeutic target in helminth immune modulation.

about

The Roles of Mast Cells in Parasitic Protozoan Infections.Helminths and intestinal barrier function.IgE and mast cells in host defense against parasites and venoms.Helminths as an alternative therapy for intestinal diseases

P2860

Q37739125-A70887B9-610C-43A7-ADB0-B9825AF4EC54 Q38815064-25EB0232-F72E-44CB-B6F2-97B50C522E31 Q38844328-7F5B065E-F6E3-4FBD-B17C-5FDB95DAA156 Q42358505-FE216AEC-7776-46DD-8D0B-BE26F4947C9A

P2860

Mast cells: new therapeutic target in helminth immune modulation.

Item

http://www.wikidata.org/entity/Q38636165

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Mast cells: new therapeutic target in helminth immune modulation.

@en

type

Item

label

Mast cells: new therapeutic target in helminth immune modulation.

@en

prefLabel

Mast cells: new therapeutic target in helminth immune modulation.

@en

P1476

Mast cells: new therapeutic target in helminth immune modulation.

@en

P2093

A Aldridge

http://www.w3.org/2001/XMLSchema#string

K V Vukman

http://www.w3.org/2001/XMLSchema#string

R Lalor

http://www.w3.org/2001/XMLSchema#string

S M O'Neill

http://www.w3.org/2001/XMLSchema#string

P2860

Trichuris suis therapy in Crohn's disease

Mast cells in inflammatory arthritis

Regulation of type 2 immunity to helminths by mast cells

Helminth infections and host immune regulation

Nematode modulation of inflammatory bowel disease

Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity

Human helminth therapy to treat inflammatory disorders - where do we stand?

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

P304

45-52

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/PIM.12295

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284171839

http://www.w3.org/2001/XMLSchema#string

P698

26577605

http://www.w3.org/2001/XMLSchema#string

P921

mast cells

Mast cells: new therapeutic target in helminth immune modulation.

about

P2860

P2860

Mast cells: new therapeutic target in helminth immune modulation.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921